Heterokaryon-Based Reprogramming of Human B Lymphocytes for Pluripotency Requires Oct4 but Not Sox2

被引:96
|
作者
Pereira, Carlos F. [1 ]
Terranova, Remi [1 ]
Ryan, Natalie K. [1 ]
Santos, Joana [1 ]
Morris, Kelly J. [1 ]
Cui, Wei [2 ]
Merkenschlager, Matthias [1 ]
Fisher, Amanda G. [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll Sch Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London, England
[2] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Inst Reprod & Dev Biol,Stem Cell Initiat, London, England
来源
PLOS GENETICS | 2008年 / 4卷 / 09期
基金
英国医学研究理事会;
关键词
D O I
10.1371/journal.pgen.1000170
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Differentiated cells can be reprogrammed through the formation of heterokaryons and hybrid cells when fused with embryonic stem (ES) cells. Here, we provide evidence that conversion of human B-lymphocytes towards a multipotent state is initiated much more rapidly than previously thought, occurring in transient heterokaryons before nuclear fusion and cell division. Interestingly, reprogramming of human lymphocytes by mouse ES cells elicits the expression of a human ES-specific gene profile, in which markers of human ES cells are expressed (hSSEA4, hFGF receptors and ligands), but markers that are specific to mouse ES cells are not (e.g., Bmp4 and LIF receptor). Using genetically engineered mouse ES cells, we demonstrate that successful reprogramming of human lymphocytes is independent of Sox2, a factor thought to be required for induced pluripotent stem (iPS) cells. In contrast, there is a distinct requirement for Oct4 in the establishment but not the maintenance of the reprogrammed state. Experimental heterokaryons, therefore, offer a powerful approach to trace the contribution of individual factors to the reprogramming of human somatic cells towards a multipotent state.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Conversion of Sox17 into a Pluripotency Reprogramming Factor by Reengineering Its Association with Oct4 on DNA
    Jauch, Ralf
    Aksoy, Irene
    Hutchins, Andrew Paul
    Ng, Calista Keow Leng
    Tian, Xian Feng
    Chen, Jiaxuan
    Palasingam, Paaventhan
    Robson, Paul
    Stanton, Lawrence W.
    Kolatkar, Prasanna R.
    [J]. STEM CELLS, 2011, 29 (06) : 940 - 951
  • [32] Dynamical reorganization of the pluripotency transcription factors Oct4 and Sox2 during early differentiation of embryonic stem cells
    Verneri, Paula
    Echegaray, Camila Vazquez
    Oses, Camila
    Stortz, Martin
    Guberman, Alejandra
    Levi, Valeria
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [33] The expression profile of Oct4 and Sox2 in the carcinogenesis of oral mucosa
    Qiao, Bin
    He, Baoxia
    Cai, Jinghua
    Yang, Wenli
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (01): : 28 - 37
  • [34] Dynamical reorganization of the pluripotency transcription factors Oct4 and Sox2 during early differentiation of embryonic stem cells
    Paula Verneri
    Camila Vazquez Echegaray
    Camila Oses
    Martin Stortz
    Alejandra Guberman
    Valeria Levi
    [J]. Scientific Reports, 10
  • [35] Hepatocyte Reprogramming to a Progenitor-Cell Phenotype Is a Potential Mechanism of Hepatocarcinogenesis - The Role of Reprogramming Factors: OCT4, SOX2 and NANOG
    Iacob, Razvan
    Vagu, Codruta D.
    Nastase, Anca
    Iacob, Speranta
    Botea, Florin
    Herlea, Vlad
    Croitoru, Adina E.
    Dima, Simona
    Gheorghe, Cristian
    Popescu, Irinel
    Ott, Michael
    Gheorghe, Liana
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S296 - S297
  • [36] Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17
    Srivastava, Yogesh
    Tan, Daisylyn Senna
    Malik, Vikas
    Weng, Mingxi
    Javed, Asif
    Cojocaru, Vlad
    Wu, Guangming
    Veerapandian, Veeramohan
    Cheung, Lydia W. T.
    Jauch, Ralf
    [J]. FEBS JOURNAL, 2020, 287 (01) : 122 - 144
  • [37] Down-regulation of Pluripotency Markers, SOX2 and OCT4, predicts a new avenue for the involvement of LSCs in pterygium development
    Rad, A.
    Najafi, M.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 849 - 849
  • [38] Effects of OCT4, SOX2 and NANOG expression on imatinib resistance in CML
    Hekmatshoar, Y.
    Ozkan, T.
    Zaim, B. Altinok
    Karadag, A.
    Sunguroglu, A.
    [J]. FEBS JOURNAL, 2014, 281 : 224 - 224
  • [39] Functional characterization of the Sox2, c-Myc, and Oct4 promoters
    Chen, Hao
    Jin, Kai
    Song, Jiuzhou
    Zuo, Qisheng
    Yang, Huilin
    Zhang, Yani
    Li, Bichun
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (01) : 332 - 342
  • [40] Rolling ES Cells Down the Waddington Landscape with Oct4 and Sox2
    Iovino, Nicola
    Cavalli, Giacomo
    [J]. CELL, 2011, 145 (06) : 815 - 817